GO:0034641 | cellular nitrogen compound metabolic process | 19.72% (42/213) | 1.44 | 0.0 | 2e-06 |
GO:0003676 | nucleic acid binding | 21.6% (46/213) | 1.25 | 0.0 | 9e-06 |
GO:0044238 | primary metabolic process | 34.74% (74/213) | 0.87 | 0.0 | 1.1e-05 |
GO:0071704 | organic substance metabolic process | 36.15% (77/213) | 0.83 | 0.0 | 1.4e-05 |
GO:0046483 | heterocycle metabolic process | 15.96% (34/213) | 1.44 | 0.0 | 1.6e-05 |
GO:0008152 | metabolic process | 37.56% (80/213) | 0.79 | 0.0 | 1.6e-05 |
GO:0044237 | cellular metabolic process | 29.11% (62/213) | 0.94 | 0.0 | 1.7e-05 |
GO:1901360 | organic cyclic compound metabolic process | 15.96% (34/213) | 1.4 | 0.0 | 2.3e-05 |
GO:0034660 | ncRNA metabolic process | 5.16% (11/213) | 2.88 | 0.0 | 3.3e-05 |
GO:0006725 | cellular aromatic compound metabolic process | 15.49% (33/213) | 1.38 | 0.0 | 3.7e-05 |
GO:0006139 | nucleobase-containing compound metabolic process | 14.55% (31/213) | 1.43 | 1e-06 | 4e-05 |
GO:0003674 | molecular_function | 68.54% (146/213) | 0.39 | 1e-06 | 5.7e-05 |
GO:0006807 | nitrogen compound metabolic process | 29.11% (62/213) | 0.86 | 1e-06 | 5.8e-05 |
GO:0009987 | cellular process | 38.5% (82/213) | 0.7 | 1e-06 | 5.8e-05 |
GO:0044281 | small molecule metabolic process | 9.86% (21/213) | 1.77 | 1e-06 | 5.9e-05 |
GO:0003723 | RNA binding | 8.92% (19/213) | 1.79 | 3e-06 | 0.000161 |
GO:0097159 | organic cyclic compound binding | 31.92% (68/213) | 0.75 | 5e-06 | 0.000215 |
GO:0005737 | cytoplasm | 4.23% (9/213) | 2.8 | 7e-06 | 0.000295 |
GO:1901566 | organonitrogen compound biosynthetic process | 8.92% (19/213) | 1.7 | 8e-06 | 0.000321 |
GO:0005488 | binding | 45.07% (96/213) | 0.51 | 2.7e-05 | 0.001066 |
GO:0090407 | organophosphate biosynthetic process | 4.23% (9/213) | 2.51 | 3.5e-05 | 0.00114 |
GO:1901576 | organic substance biosynthetic process | 12.21% (26/213) | 1.26 | 3.4e-05 | 0.001168 |
GO:0006399 | tRNA metabolic process | 3.29% (7/213) | 2.98 | 3.4e-05 | 0.001219 |
GO:0009058 | biosynthetic process | 12.68% (27/213) | 1.24 | 3.4e-05 | 0.001268 |
GO:0016874 | ligase activity | 3.76% (8/213) | 2.62 | 5.5e-05 | 0.00175 |
GO:0034470 | ncRNA processing | 3.29% (7/213) | 2.84 | 6.1e-05 | 0.001787 |
GO:0008150 | biological_process | 50.23% (107/213) | 0.44 | 5.9e-05 | 0.001793 |
GO:0090304 | nucleic acid metabolic process | 10.8% (23/213) | 1.3 | 6.7e-05 | 0.001823 |
GO:0044249 | cellular biosynthetic process | 11.27% (24/213) | 1.27 | 6.6e-05 | 0.001857 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 8.45% (18/213) | 1.46 | 0.000115 | 0.002928 |
GO:0006099 | tricarboxylic acid cycle | 1.88% (4/213) | 4.01 | 0.000112 | 0.002958 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 0.94% (2/213) | 6.53 | 0.000172 | 0.004128 |
GO:0004826 | phenylalanine-tRNA ligase activity | 0.94% (2/213) | 6.53 | 0.000172 | 0.004128 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 1.88% (4/213) | 3.78 | 0.00021 | 0.004891 |
GO:0003824 | catalytic activity | 38.5% (82/213) | 0.5 | 0.000246 | 0.005548 |
GO:0072527 | pyrimidine-containing compound metabolic process | 1.88% (4/213) | 3.7 | 0.00026 | 0.005697 |
GO:0043170 | macromolecule metabolic process | 23.0% (49/213) | 0.7 | 0.000333 | 0.00711 |
GO:0006007 | glucose catabolic process | 0.94% (2/213) | 5.73 | 0.000597 | 0.010255 |
GO:0006621 | protein retention in ER lumen | 0.94% (2/213) | 5.73 | 0.000597 | 0.010255 |
GO:0032507 | maintenance of protein location in cell | 0.94% (2/213) | 5.73 | 0.000597 | 0.010255 |
GO:0072595 | maintenance of protein localization in organelle | 0.94% (2/213) | 5.73 | 0.000597 | 0.010255 |
GO:0035437 | maintenance of protein localization in endoplasmic reticulum | 0.94% (2/213) | 5.73 | 0.000597 | 0.010255 |
GO:0045185 | maintenance of protein location | 0.94% (2/213) | 5.73 | 0.000597 | 0.010255 |
GO:0046923 | ER retention sequence binding | 0.94% (2/213) | 5.73 | 0.000597 | 0.010255 |
GO:0051651 | maintenance of location in cell | 0.94% (2/213) | 5.73 | 0.000597 | 0.010255 |
GO:1901564 | organonitrogen compound metabolic process | 19.72% (42/213) | 0.73 | 0.000622 | 0.010455 |
GO:0140101 | catalytic activity, acting on a tRNA | 2.35% (5/213) | 2.87 | 0.000649 | 0.010683 |
GO:0140098 | catalytic activity, acting on RNA | 4.23% (9/213) | 1.98 | 0.000524 | 0.010901 |
GO:0046365 | monosaccharide catabolic process | 0.94% (2/213) | 5.53 | 0.000793 | 0.012289 |
GO:0019320 | hexose catabolic process | 0.94% (2/213) | 5.53 | 0.000793 | 0.012289 |
GO:0008964 | phosphoenolpyruvate carboxylase activity | 0.94% (2/213) | 5.53 | 0.000793 | 0.012289 |
GO:0110165 | cellular anatomical entity | 15.49% (33/213) | 0.83 | 0.000855 | 0.012988 |
GO:0051235 | maintenance of location | 0.94% (2/213) | 5.36 | 0.001016 | 0.015149 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3.76% (8/213) | 1.98 | 0.001046 | 0.015302 |
GO:0042364 | water-soluble vitamin biosynthetic process | 1.41% (3/213) | 3.83 | 0.001225 | 0.01759 |
GO:1901293 | nucleoside phosphate biosynthetic process | 2.35% (5/213) | 2.58 | 0.00158 | 0.017829 |
GO:0009165 | nucleotide biosynthetic process | 2.35% (5/213) | 2.58 | 0.00158 | 0.017829 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 0.94% (2/213) | 5.21 | 0.001266 | 0.017859 |
GO:0007093 | mitotic cell cycle checkpoint signaling | 0.94% (2/213) | 5.08 | 0.001542 | 0.017912 |
GO:0045930 | negative regulation of mitotic cell cycle | 0.94% (2/213) | 5.08 | 0.001542 | 0.017912 |
GO:0016763 | pentosyltransferase activity | 1.41% (3/213) | 3.8 | 0.001319 | 0.017961 |
GO:0019637 | organophosphate metabolic process | 4.69% (10/213) | 1.67 | 0.00135 | 0.018077 |
GO:0006767 | water-soluble vitamin metabolic process | 1.41% (3/213) | 3.69 | 0.001628 | 0.018111 |
GO:0016070 | RNA metabolic process | 6.57% (14/213) | 1.36 | 0.001308 | 0.018125 |
GO:0004812 | aminoacyl-tRNA ligase activity | 1.88% (4/213) | 3.03 | 0.001523 | 0.018232 |
GO:0043039 | tRNA aminoacylation | 1.88% (4/213) | 3.03 | 0.001523 | 0.018232 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 1.88% (4/213) | 3.03 | 0.001523 | 0.018232 |
GO:0043038 | amino acid activation | 1.88% (4/213) | 3.03 | 0.001523 | 0.018232 |
GO:0009110 | vitamin biosynthetic process | 1.41% (3/213) | 3.76 | 0.001417 | 0.018354 |
GO:0006418 | tRNA aminoacylation for protein translation | 1.88% (4/213) | 3.06 | 0.001403 | 0.018475 |
GO:0010564 | regulation of cell cycle process | 1.41% (3/213) | 3.73 | 0.00152 | 0.01937 |
GO:0006766 | vitamin metabolic process | 1.41% (3/213) | 3.63 | 0.001857 | 0.020374 |
GO:0005575 | cellular_component | 19.25% (41/213) | 0.66 | 0.001918 | 0.020754 |
GO:0018130 | heterocycle biosynthetic process | 4.69% (10/213) | 1.58 | 0.002116 | 0.022589 |
GO:0015977 | carbon fixation | 0.94% (2/213) | 4.83 | 0.002171 | 0.022868 |
GO:0006364 | rRNA processing | 1.88% (4/213) | 2.85 | 0.002396 | 0.024911 |
GO:0004619 | phosphoglycerate mutase activity | 0.94% (2/213) | 4.73 | 0.002524 | 0.025562 |
GO:0006400 | tRNA modification | 1.41% (3/213) | 3.48 | 0.002515 | 0.025799 |
GO:0000075 | cell cycle checkpoint signaling | 0.94% (2/213) | 4.63 | 0.002902 | 0.027957 |
GO:0010948 | negative regulation of cell cycle process | 0.94% (2/213) | 4.63 | 0.002902 | 0.027957 |
GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors | 0.94% (2/213) | 4.63 | 0.002902 | 0.027957 |
GO:1901988 | negative regulation of cell cycle phase transition | 0.94% (2/213) | 4.63 | 0.002902 | 0.027957 |
GO:0016072 | rRNA metabolic process | 1.88% (4/213) | 2.77 | 0.002941 | 0.027992 |
GO:0003684 | damaged DNA binding | 0.94% (2/213) | 4.45 | 0.003732 | 0.034686 |
GO:0005524 | ATP binding | 12.21% (26/213) | 0.81 | 0.003714 | 0.034933 |
GO:1901362 | organic cyclic compound biosynthetic process | 4.69% (10/213) | 1.45 | 0.003947 | 0.036253 |
GO:0016830 | carbon-carbon lyase activity | 1.88% (4/213) | 2.63 | 0.004148 | 0.037666 |
GO:0035639 | purine ribonucleoside triphosphate binding | 13.15% (28/213) | 0.76 | 0.004252 | 0.038172 |
GO:0006396 | RNA processing | 3.76% (8/213) | 1.65 | 0.00431 | 0.038259 |
GO:0042277 | peptide binding | 0.94% (2/213) | 4.29 | 0.004659 | 0.039579 |
GO:0005048 | signal sequence binding | 0.94% (2/213) | 4.29 | 0.004659 | 0.039579 |
GO:0004611 | phosphoenolpyruvate carboxykinase activity | 0.94% (2/213) | 4.29 | 0.004659 | 0.039579 |
GO:0000049 | tRNA binding | 0.94% (2/213) | 4.29 | 0.004659 | 0.039579 |
GO:0003721 | telomerase RNA reverse transcriptase activity | 0.47% (1/213) | 7.53 | 0.005393 | 0.040191 |
GO:0003964 | RNA-directed DNA polymerase activity | 0.47% (1/213) | 7.53 | 0.005393 | 0.040191 |
GO:0007095 | mitotic G2 DNA damage checkpoint signaling | 0.47% (1/213) | 7.53 | 0.005393 | 0.040191 |
GO:0044773 | mitotic DNA damage checkpoint signaling | 0.47% (1/213) | 7.53 | 0.005393 | 0.040191 |
GO:0080008 | Cul4-RING E3 ubiquitin ligase complex | 0.47% (1/213) | 7.53 | 0.005393 | 0.040191 |
GO:0071951 | conversion of methionyl-tRNA to N-formyl-methionyl-tRNA | 0.47% (1/213) | 7.53 | 0.005393 | 0.040191 |
GO:0004639 | phosphoribosylaminoimidazolesuccinocarboxamide synthase activity | 0.47% (1/213) | 7.53 | 0.005393 | 0.040191 |
GO:0006285 | base-excision repair, AP site formation | 0.47% (1/213) | 7.53 | 0.005393 | 0.040191 |
GO:0004479 | methionyl-tRNA formyltransferase activity | 0.47% (1/213) | 7.53 | 0.005393 | 0.040191 |
GO:0007346 | regulation of mitotic cell cycle | 0.94% (2/213) | 4.14 | 0.005682 | 0.041948 |
GO:0016779 | nucleotidyltransferase activity | 2.35% (5/213) | 2.14 | 0.005789 | 0.042345 |
GO:0022402 | cell cycle process | 1.88% (4/213) | 2.53 | 0.005211 | 0.04288 |
GO:0003677 | DNA binding | 9.39% (20/213) | 0.91 | 0.005292 | 0.043103 |
GO:0097367 | carbohydrate derivative binding | 13.62% (29/213) | 0.72 | 0.005205 | 0.043287 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 0.94% (2/213) | 4.21 | 0.005159 | 0.043355 |
GO:0051726 | regulation of cell cycle | 1.41% (3/213) | 3.03 | 0.00599 | 0.043411 |
GO:0019438 | aromatic compound biosynthetic process | 4.23% (9/213) | 1.44 | 0.006363 | 0.045701 |
GO:0045786 | negative regulation of cell cycle | 0.94% (2/213) | 4.01 | 0.006797 | 0.047941 |
GO:0016868 | intramolecular phosphotransferase activity | 0.94% (2/213) | 4.01 | 0.006797 | 0.047941 |
GO:0032559 | adenyl ribonucleotide binding | 12.21% (26/213) | 0.74 | 0.006899 | 0.048235 |